{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T15:58:17Z","timestamp":1792425497308,"version":"4.5.0"},"reference-count":99,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:00:00Z","timestamp":1760140800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:00:00Z","timestamp":1760140800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Osteoporos Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11914-025-00941-2","type":"journal-article","created":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T02:32:35Z","timestamp":1760149955000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Leveraging Proteomics and Proteogenomics for Understanding Osteoporosis and Other Musculoskeletal Diseases"],"prefix":"10.1007","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7031-2446","authenticated-orcid":false,"given":"Masashi","family":"Hasebe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6071-4660","authenticated-orcid":false,"given":"Chen-Yang","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8474-0310","authenticated-orcid":false,"given":"Douglas P.","family":"Kiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8863-2413","authenticated-orcid":false,"given":"Satoshi","family":"Yoshiji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,11]]},"reference":[{"issue":"3","key":"941_CR1","doi-asserted-by":"publisher","first-page":"ITC17","DOI":"10.7326\/AITC201708010","volume":"167","author":"KE Ensrud","year":"2017","unstructured":"Ensrud KE, Crandall CJ. Osteoporosis. Ann Intern Med. 2017;167(3):ITC17\u201332. https:\/\/doi.org\/10.7326\/AITC201708010.","journal-title":"Ann Intern Med"},{"issue":"9","key":"941_CR2","doi-asserted-by":"publisher","first-page":"e580","DOI":"10.1016\/S2666-7568(21)00172-0","volume":"2","author":"GBDF Collaborators","year":"2021","unstructured":"Collaborators GBDF. Global, regional, and national burden of bone fractures in 204 countries and territories, 1990\u20132019: a systematic analysis from the Global Burden of Disease Study 2019. Lancet Healthy Longev. 2021;2(9):e580\u201392. https:\/\/doi.org\/10.1016\/S2666-7568(21)00172-0.","journal-title":"Lancet Healthy Longev"},{"issue":"8","key":"941_CR3","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1002\/jbmr.4821","volume":"38","author":"CW Sing","year":"2023","unstructured":"Sing CW, Lin TC, Bartholomew S, Bell JS, Bennett C, Beyene K, et al. Global epidemiology of hip fractures: secular trends in incidence rate, post-fracture treatment, and all-cause mortality. J Bone Miner Res. 2023;38(8):1064\u201375. https:\/\/doi.org\/10.1002\/jbmr.4821.","journal-title":"J Bone Miner Res"},{"key":"941_CR4","doi-asserted-by":"publisher","first-page":"16072","DOI":"10.1038\/nrdp.2016.72","volume":"2","author":"J Martel-Pelletier","year":"2016","unstructured":"Martel-Pelletier J, Barr AJ, Cicuttini FM, Conaghan PG, Cooper C, Goldring MB, et al. Osteoarthritis. Nat Rev Dis Primers. 2016;2:16072. https:\/\/doi.org\/10.1038\/nrdp.2016.72.","journal-title":"Nat Rev Dis Primers"},{"issue":"9","key":"941_CR5","doi-asserted-by":"publisher","first-page":"e508","DOI":"10.1016\/S2665-9913(23)00163-7","volume":"5","author":"Collaborators GBDO","year":"2023","unstructured":"Collaborators GBDO. Global, regional, and national burden of osteoarthritis, 1990\u20132020 and projections to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Rheumatol. 2023;5(9):e508\u201322. https:\/\/doi.org\/10.1016\/S2665-9913(23)00163-7.","journal-title":"Lancet Rheumatol"},{"issue":"10191","key":"941_CR6","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1016\/S0140-6736(19)31138-9","volume":"393","author":"AJ Cruz-Jentoft","year":"2019","unstructured":"Cruz-Jentoft AJ, Sayer AA. Sarcopenia. Lancet. 2019;393(10191):2636\u201346. https:\/\/doi.org\/10.1016\/S0140-6736(19)31138-9.","journal-title":"Lancet"},{"issue":"1","key":"941_CR7","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1002\/jcsm.12783","volume":"13","author":"F Petermann-Rocha","year":"2022","unstructured":"Petermann-Rocha F, Balntzi V, Gray SR, Lara J, Ho FK, Pell JP, et al. Global prevalence of sarcopenia and severe sarcopenia: a systematic review and meta-analysis. J Cachexia Sarcopenia Muscle. 2022;13(1):86\u201399. https:\/\/doi.org\/10.1002\/jcsm.12783.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"941_CR8","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afae052","author":"B Kirk","year":"2024","unstructured":"Kirk B, Cawthon PM, Arai H, Avila-Funes JA, Barazzoni R, Bhasin S, et al. The conceptual definition of sarcopenia: delphi consensus from the Global Leadership Initiative in Sarcopenia (GLIS). Age Ageing. 2024. https:\/\/doi.org\/10.1093\/ageing\/afae052.","journal-title":"Age Ageing"},{"issue":"3","key":"941_CR9","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/ng1106","volume":"33","author":"SD Patterson","year":"2003","unstructured":"Patterson SD, Aebersold RH. Proteomics: the first decade and beyond. Nat Genet. 2003;33(3):311\u201323. https:\/\/doi.org\/10.1038\/ng1106.","journal-title":"Nat Genet"},{"issue":"10","key":"941_CR10","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1038\/s41588-020-0682-6","volume":"52","author":"J Zheng","year":"2020","unstructured":"Zheng J, Haberland V, Baird D, Walker V, Haycock PC, Hurle MR, et al. Phenome-wide Mendelian randomization mapping the influence of the plasma proteome on complex diseases. Nat Genet. 2020;52(10):1122\u201331. https:\/\/doi.org\/10.1038\/s41588-020-0682-6.","journal-title":"Nat Genet"},{"issue":"8","key":"941_CR11","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1056\/NEJMoa0809493","volume":"361","author":"SR Cummings","year":"2009","unstructured":"Cummings SR, San Martin J, McClung MR, Siris ES, Eastell R, Reid IR, et al. Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med. 2009;361(8):756\u201365. https:\/\/doi.org\/10.1056\/NEJMoa0809493.","journal-title":"N Engl J Med"},{"issue":"7","key":"941_CR12","doi-asserted-by":"publisher","first-page":"2599","DOI":"10.1210\/jc.2013-4175","volume":"99","author":"T Nakamura","year":"2014","unstructured":"Nakamura T, Matsumoto T, Sugimoto T, Hosoi T, Miki T, Gorai I, et al. Clinical trials express: fracture risk reduction with denosumab in Japanese postmenopausal women and men with osteoporosis: denosumab fracture intervention randomized placebo controlled trial (DIRECT). J Clin Endocrinol Metab. 2014;99(7):2599\u2013607. https:\/\/doi.org\/10.1210\/jc.2013-4175.","journal-title":"J Clin Endocrinol Metab"},{"issue":"16","key":"941_CR13","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1056\/NEJMoa1607948","volume":"375","author":"F Cosman","year":"2016","unstructured":"Cosman F, Crittenden DB, Adachi JD, Binkley N, Czerwinski E, Ferrari S, et al. Romosozumab treatment in postmenopausal women with osteoporosis. N Engl J Med. 2016;375(16):1532\u201343. https:\/\/doi.org\/10.1056\/NEJMoa1607948.","journal-title":"N Engl J Med"},{"issue":"15","key":"941_CR14","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1056\/NEJMoa1708322","volume":"377","author":"KG Saag","year":"2017","unstructured":"Saag KG, Petersen J, Brandi ML, Karaplis AC, Lorentzon M, Thomas T, et al. Romosozumab or alendronate for fracture prevention in women with osteoporosis. N Engl J Med. 2017;377(15):1417\u201327. https:\/\/doi.org\/10.1056\/NEJMoa1708322.","journal-title":"N Engl J Med"},{"issue":"14","key":"941_CR15","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1001\/jama.2019.14735","volume":"322","author":"MC Hochberg","year":"2019","unstructured":"Hochberg MC, Guermazi A, Guehring H, Aydemir A, Wax S, Fleuranceau-Morel P, et al. Effect of intra-articular Sprifermin vs placebo on femorotibial joint cartilage thickness in patients with osteoarthritis: the FORWARD randomized clinical trial. JAMA. 2019;322(14):1360\u201370. https:\/\/doi.org\/10.1001\/jama.2019.14735.","journal-title":"JAMA"},{"issue":"10","key":"941_CR16","doi-asserted-by":"publisher","first-page":"e2020836","DOI":"10.1001\/jamanetworkopen.2020.20836","volume":"3","author":"D Rooks","year":"2020","unstructured":"Rooks D, Swan T, Goswami B, Filosa LA, Bunte O, Panchaud N, et al. Bimagrumab vs optimized standard of care for treatment of sarcopenia in community-dwelling older adults: a randomized clinical trial. JAMA Netw Open. 2020;3(10):e2020836. https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.20836.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"941_CR17","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/nbt.2786","volume":"32","author":"M Hay","year":"2014","unstructured":"Hay M, Thomas DW, Craighead JL, Economides C, Rosenthal J. Clinical development success rates for investigational drugs. Nat Biotechnol. 2014;32(1):40\u201351. https:\/\/doi.org\/10.1038\/nbt.2786.","journal-title":"Nat Biotechnol"},{"issue":"6716","key":"941_CR18","doi-asserted-by":"publisher","first-page":"eads5749","DOI":"10.1126\/science.ads5749","volume":"385","author":"EJ Topol","year":"2024","unstructured":"Topol EJ. The revolution in high-throughput proteomics and AI. Science. 2024;385(6716):eads5749. https:\/\/doi.org\/10.1126\/science.ads5749.","journal-title":"Science"},{"issue":"5","key":"941_CR19","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/nbt0502-473","volume":"20","author":"S Fredriksson","year":"2002","unstructured":"Fredriksson S, Gullberg M, Jarvius J, Olsson C, Pietras K, Gustafsdottir SM, et al. Protein detection using proximity-dependent DNA ligation assays. Nat Biotechnol. 2002;20(5):473\u20137. https:\/\/doi.org\/10.1038\/nbt0502-473.","journal-title":"Nat Biotechnol"},{"issue":"15","key":"941_CR20","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkr424","volume":"39","author":"M Lundberg","year":"2011","unstructured":"Lundberg M, Eriksson A, Tran B, Assarsson E, Fredriksson S. Homogeneous antibody-based proximity extension assays provide sensitive and specific detection of low-abundant proteins in human blood. Nucleic Acids Res. 2011;39(15):e102. https:\/\/doi.org\/10.1093\/nar\/gkr424.","journal-title":"Nucleic Acids Res"},{"issue":"12","key":"941_CR21","doi-asserted-by":"publisher","first-page":"e15004","DOI":"10.1371\/journal.pone.0015004","volume":"5","author":"L Gold","year":"2010","unstructured":"Gold L, Ayers D, Bertino J, Bock C, Bock A, Brody EN, et al. Aptamer-based multiplexed proteomic technology for biomarker discovery. PLoS ONE. 2010;5(12):e15004. https:\/\/doi.org\/10.1371\/journal.pone.0015004.","journal-title":"PLoS ONE"},{"issue":"1","key":"941_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s43586-021-00056-9","volume":"1","author":"E Uffelmann","year":"2021","unstructured":"Uffelmann E, Huang QQ, Munung NS, de Vries J, Okada Y, Martin AR, et al. Genome-wide association studies. Nat Rev Methods Primers. 2021;1(1):59. https:\/\/doi.org\/10.1038\/s43586-021-00056-9.","journal-title":"Nat Rev Methods Primers"},{"issue":"1","key":"941_CR23","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s41576-023-00637-2","volume":"25","author":"L Kachuri","year":"2024","unstructured":"Kachuri L, Chatterjee N, Hirbo J, Schaid DJ, Martin I, Kullo IJ, et al. Principles and methods for transferring polygenic risk scores across global populations. Nat Rev Genet. 2024;25(1):8\u201325. https:\/\/doi.org\/10.1038\/s41576-023-00637-2.","journal-title":"Nat Rev Genet"},{"issue":"12","key":"941_CR24","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1038\/s41588-021-00978-w","volume":"53","author":"E Ferkingstad","year":"2021","unstructured":"Ferkingstad E, Sulem P, Atlason BA, Sveinbjornsson G, Magnusson MI, Styrmisdottir EL, et al. Large-scale integration of the plasma proteome with genetics and disease. Nat Genet. 2021;53(12):1712\u201321. https:\/\/doi.org\/10.1038\/s41588-021-00978-w.","journal-title":"Nat Genet"},{"issue":"9","key":"941_CR25","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1038\/s41590-023-01588-w","volume":"24","author":"JH Zhao","year":"2023","unstructured":"Zhao JH, Stacey D, Eriksson N, Macdonald-Dunlop E, Hedman AK, Kalnapenkis A, et al. Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets. Nat Immunol. 2023;24(9):1540\u201351. https:\/\/doi.org\/10.1038\/s41590-023-01588-w.","journal-title":"Nat Immunol"},{"key":"941_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s43586-021-00092-5","author":"E Sanderson","year":"2022","unstructured":"Sanderson E, Glymour MM, Holmes MV, Kang H, Morrison J, Munafo MR, et al. Mendelian randomization. Nat Rev Methods Primers. 2022. https:\/\/doi.org\/10.1038\/s43586-021-00092-5.","journal-title":"Nat Rev Methods Primers"},{"issue":"10","key":"941_CR27","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1002\/jbmr.3803","volume":"34","author":"J Zheng","year":"2019","unstructured":"Zheng J, Maerz W, Gergei I, Kleber M, Drechsler C, Wanner C, et al. Mendelian randomization analysis reveals a causal influence of circulating sclerostin levels on bone mineral density and fractures. J Bone Miner Res. 2019;34(10):1824\u201336. https:\/\/doi.org\/10.1002\/jbmr.3803.","journal-title":"J Bone Miner Res"},{"issue":"2","key":"941_CR28","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/s42255-023-00742-w","volume":"5","author":"S Yoshiji","year":"2023","unstructured":"Yoshiji S, Butler-Laporte G, Lu T, Willett JDS, Su CY, Nakanishi T, et al. Proteome-wide Mendelian randomization implicates nephronectin as an actionable mediator of the effect of obesity on COVID-19 severity. Nat Metab. 2023;5(2):248\u201364. https:\/\/doi.org\/10.1038\/s42255-023-00742-w.","journal-title":"Nat Metab"},{"issue":"2","key":"941_CR29","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/s41588-024-02052-7","volume":"57","author":"S Yoshiji","year":"2025","unstructured":"Yoshiji S, Lu T, Butler-Laporte G, Carrasco-Zanini-Sanchez J, Su CY, Chen Y, et al. Integrative proteogenomic analysis identifies COL6A3-derived endotrophin as a mediator of the effect of obesity on coronary artery disease. Nat Genet. 2025;57(2):345\u201357. https:\/\/doi.org\/10.1038\/s41588-024-02052-7.","journal-title":"Nat Genet"},{"issue":"4","key":"941_CR30","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s11914-021-00684-w","volume":"19","author":"A Abood","year":"2021","unstructured":"Abood A, Farber CR. Using \u201c-omics\u201d Data to inform Genome-wide Association Studies (GWASs) in the osteoporosis field. Curr Osteoporos Rep. 2021;19(4):369\u201380. https:\/\/doi.org\/10.1007\/s11914-021-00684-w.","journal-title":"Curr Osteoporos Rep"},{"issue":"7982","key":"941_CR31","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/s41586-023-06592-6","volume":"622","author":"BB Sun","year":"2023","unstructured":"Sun BB, Chiou J, Traylor M, Benner C, Hsu YH, Richardson TG, et al. Plasma proteomic associations with genetics and health in the UK biobank. Nature. 2023;622(7982):329\u201338. https:\/\/doi.org\/10.1038\/s41586-023-06592-6.","journal-title":"Nature"},{"key":"941_CR32","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.bone.2019.04.005","volume":"126","author":"K Trajanoska","year":"2019","unstructured":"Trajanoska K, Rivadeneira F. The genetic architecture of osteoporosis and fracture risk. Bone. 2019;126:2\u201310. https:\/\/doi.org\/10.1016\/j.bone.2019.04.005.","journal-title":"Bone"},{"issue":"2","key":"941_CR33","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/s41588-018-0302-x","volume":"51","author":"JA Morris","year":"2019","unstructured":"Morris JA, Kemp JP, Youlten SE, Laurent L, Logan JG, Chai RC, et al. An atlas of genetic influences on osteoporosis in humans and mice. Nat Genet. 2019;51(2):258\u201366. https:\/\/doi.org\/10.1038\/s41588-018-0302-x.","journal-title":"Nat Genet"},{"issue":"2","key":"941_CR34","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41574-019-0282-7","volume":"16","author":"TL Yang","year":"2020","unstructured":"Yang TL, Shen H, Liu A, Dong SS, Zhang L, Deng FY, et al. A road map for understanding molecular and genetic determinants of osteoporosis. Nat Rev Endocrinol. 2020;16(2):91\u2013103. https:\/\/doi.org\/10.1038\/s41574-019-0282-7.","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"941_CR35","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/ng.3506","volume":"48","author":"A Gusev","year":"2016","unstructured":"Gusev A, Ko A, Shi H, Bhatia G, Chung W, Penninx BW, et al. Integrative approaches for large-scale transcriptome-wide association studies. Nat Genet. 2016;48(3):245\u201352. https:\/\/doi.org\/10.1038\/ng.3506.","journal-title":"Nat Genet"},{"issue":"4","key":"941_CR36","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/nrg3185","volume":"13","author":"C Vogel","year":"2012","unstructured":"Vogel C, Marcotte EM. Insights into the regulation of protein abundance from proteomic and transcriptomic analyses. Nat Rev Genet. 2012;13(4):227\u201332. https:\/\/doi.org\/10.1038\/nrg3185.","journal-title":"Nat Rev Genet"},{"issue":"3","key":"941_CR37","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1038\/s42255-023-00753-7","volume":"5","author":"M Koprulu","year":"2023","unstructured":"Koprulu M, Carrasco-Zanini J, Wheeler E, Lockhart S, Kerrison ND, Wareham NJ, et al. Proteogenomic links to human metabolic diseases. Nat Metab. 2023;5(3):516\u201328. https:\/\/doi.org\/10.1038\/s42255-023-00753-7.","journal-title":"Nat Metab"},{"key":"941_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2024.10.019","author":"Y Zheng","year":"2024","unstructured":"Zheng Y, Li J, Li Y, Wang J, Suo C, Jiang Y, et al. Plasma proteomic profiles reveal proteins and three characteristic patterns associated with osteoporosis: A prospective cohort study. J Adv Res. 2024. https:\/\/doi.org\/10.1016\/j.jare.2024.10.019.","journal-title":"J Adv Res"},{"issue":"2","key":"941_CR39","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/nrendo.2011.207","volume":"8","author":"R Baron","year":"2011","unstructured":"Baron R. Osteoporosis in 2011: Osteoporosis therapy\u2013dawn of the post-bisphosphonate era. Nat Rev Endocrinol. 2011;8(2):76\u20138. https:\/\/doi.org\/10.1038\/nrendo.2011.207.","journal-title":"Nat Rev Endocrinol"},{"issue":"8","key":"941_CR40","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1038\/s43587-024-00639-7","volume":"4","author":"TR Austin","year":"2024","unstructured":"Austin TR, Nethander M, Fink HA, Tornqvist AE, Jalal DI, Buzkova P, et al. A plasma protein-based risk score to predict hip fractures. Nat Aging. 2024;4(8):1064\u201375. https:\/\/doi.org\/10.1038\/s43587-024-00639-7.","journal-title":"Nat Aging"},{"issue":"9","key":"941_CR41","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1038\/s41591-024-03164-7","volume":"30","author":"MA Argentieri","year":"2024","unstructured":"Argentieri MA, Xiao S, Bennett D, Winchester L, Nevado-Holgado AJ, Ghose U, et al. Proteomic aging clock predicts mortality and risk of common age-related diseases in diverse populations. Nat Med. 2024;30(9):2450\u201360. https:\/\/doi.org\/10.1038\/s41591-024-03164-7.","journal-title":"Nat Med"},{"issue":"9","key":"941_CR42","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1038\/s41591-024-03142-z","volume":"30","author":"J Carrasco-Zanini","year":"2024","unstructured":"Carrasco-Zanini J, Pietzner M, Davitte J, Surendran P, Croteau-Chonka DC, Robins C, et al. Proteomic signatures improve risk prediction for common and rare diseases. Nat Med. 2024;30(9):2489\u201398. https:\/\/doi.org\/10.1038\/s41591-024-03142-z.","journal-title":"Nat Med"},{"issue":"1","key":"941_CR43","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.cell.2024.10.045","volume":"188","author":"YT Deng","year":"2025","unstructured":"Deng YT, You J, He Y, Zhang Y, Li HY, Wu XR, et al. Atlas of the plasma proteome in health and disease in 53,026 adults. Cell. 2025;188(1):253-71 e7. https:\/\/doi.org\/10.1016\/j.cell.2024.10.045.","journal-title":"Cell."},{"key":"941_CR44","doi-asserted-by":"publisher","first-page":"k3225","DOI":"10.1136\/bmj.k3225","volume":"362","author":"K Trajanoska","year":"2018","unstructured":"Trajanoska K, Morris JA, Oei L, Zheng HF, Evans DM, Kiel DP, et al. Assessment of the genetic and clinical determinants of fracture risk: genome wide association and mendelian randomisation study. BMJ. 2018;362:k3225. https:\/\/doi.org\/10.1136\/bmj.k3225.","journal-title":"BMJ"},{"issue":"9912","key":"941_CR45","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/S0140-6736(13)61647-5","volume":"383","author":"IR Reid","year":"2014","unstructured":"Reid IR, Bolland MJ, Grey A. Effects of vitamin D supplements on bone mineral density: a systematic review and meta-analysis. Lancet. 2014;383(9912):146\u201355. https:\/\/doi.org\/10.1016\/S0140-6736(13)61647-5.","journal-title":"Lancet"},{"issue":"11","key":"941_CR46","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/S2213-8587(18)30265-1","volume":"6","author":"MJ Bolland","year":"2018","unstructured":"Bolland MJ, Grey A, Avenell A. Effects of vitamin D supplementation on musculoskeletal health: a systematic review, meta-analysis, and trial sequential analysis. Lancet Diabetes Endocrinol. 2018;6(11):847\u201358. https:\/\/doi.org\/10.1016\/S2213-8587(18)30265-1.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"941_CR47","doi-asserted-by":"publisher","first-page":"n2233","DOI":"10.1136\/bmj.n2233","volume":"375","author":"VW Skrivankova","year":"2021","unstructured":"Skrivankova VW, Richmond RC, Woolf BAR, Davies NM, Swanson SA, VanderWeele TJ, et al. Strengthening the reporting of observational studies in epidemiology using mendelian randomisation (STROBE-MR): explanation and elaboration. BMJ. 2021;375:n2233. https:\/\/doi.org\/10.1136\/bmj.n2233.","journal-title":"BMJ"},{"issue":"1","key":"941_CR48","doi-asserted-by":"publisher","first-page":"4923","DOI":"10.1038\/s41467-021-25124-2","volume":"12","author":"KH Nilsson","year":"2021","unstructured":"Nilsson KH, Henning P, El Shahawy M, Nethander M, Andersen TL, Ejersted C, et al. RSPO3 is important for trabecular bone and fracture risk in mice and humans. Nat Commun. 2021;12(1):4923. https:\/\/doi.org\/10.1038\/s41467-021-25124-2.","journal-title":"Nat Commun"},{"issue":"8","key":"941_CR49","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1038\/s41588-023-01444-5","volume":"55","author":"S Zhou","year":"2023","unstructured":"Zhou S, Sosina OA, Bovijn J, Laurent L, Sharma V, Akbari P, et al. Converging evidence from exome sequencing and common variants implicates target genes for osteoporosis. Nat Genet. 2023;55(8):1277\u201387. https:\/\/doi.org\/10.1038\/s41588-023-01444-5.","journal-title":"Nat Genet"},{"key":"941_CR50","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.metabol.2017.10.005","volume":"80","author":"A Sebastian","year":"2018","unstructured":"Sebastian A, Loots GG. Genetics of Sost\/SOST in sclerosteosis and van Buchem disease animal models. Metabolism. 2018;80:38\u201347. https:\/\/doi.org\/10.1016\/j.metabol.2017.10.005.","journal-title":"Metabolism"},{"issue":"10","key":"941_CR51","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/nrendo.2013.154","volume":"9","author":"E Canalis","year":"2013","unstructured":"Canalis E. Wnt signalling in osteoporosis: mechanisms and novel therapeutic approaches. Nat Rev Endocrinol. 2013;9(10):575\u201383. https:\/\/doi.org\/10.1038\/nrendo.2013.154.","journal-title":"Nat Rev Endocrinol"},{"key":"941_CR52","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2024.1426261","volume":"11","author":"J Yan","year":"2024","unstructured":"Yan J, Huai Y, Liang Q, Lin L, Liao B. Proteome-wide Mendelian randomization provides novel insights into the pathogenesis and druggable targets of osteoporosis. Front Med. 2024;11:1426261. https:\/\/doi.org\/10.3389\/fmed.2024.1426261.","journal-title":"Front Med"},{"issue":"2","key":"941_CR53","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.cell.2006.01.051","volume":"125","author":"L Sun","year":"2006","unstructured":"Sun L, Peng Y, Sharrow AC, Iqbal J, Zhang Z, Papachristou DJ, et al. FSH directly regulates bone mass. Cell. 2006;125(2):247\u201360. https:\/\/doi.org\/10.1016\/j.cell.2006.01.051.","journal-title":"Cell"},{"issue":"4","key":"941_CR54","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1210\/jc.2005-1836","volume":"91","author":"MR Sowers","year":"2006","unstructured":"Sowers MR, Jannausch M, McConnell D, Little R, Greendale GA, Finkelstein JS, et al. Hormone predictors of bone mineral density changes during the menopausal transition. J Clin Endocrinol Metab. 2006;91(4):1261\u20137. https:\/\/doi.org\/10.1210\/jc.2005-1836.","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"941_CR55","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.1210\/en.2018-00601","volume":"159","author":"M Zaidi","year":"2018","unstructured":"Zaidi M, Lizneva D, Kim SM, Sun L, Iqbal J, New MI, et al. FSH, bone mass, body fat, and biological aging. Endocrinology. 2018;159(10):3503\u201314. https:\/\/doi.org\/10.1210\/en.2018-00601.","journal-title":"Endocrinology"},{"issue":"7","key":"941_CR56","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/nrrheum.2016.65","volume":"12","author":"RF Loeser","year":"2016","unstructured":"Loeser RF, Collins JA, Diekman BO. Ageing and the pathogenesis of osteoarthritis. Nat Rev Rheumatol. 2016;12(7):412\u201320. https:\/\/doi.org\/10.1038\/nrrheum.2016.65.","journal-title":"Nat Rev Rheumatol"},{"issue":"10","key":"941_CR57","doi-asserted-by":"publisher","first-page":"2781","DOI":"10.1007\/s00198-017-4151-8","volume":"28","author":"HP Hirschfeld","year":"2017","unstructured":"Hirschfeld HP, Kinsella R, Duque G. Osteosarcopenia: where bone, muscle, and fat collide. Osteoporos Int. 2017;28(10):2781\u201390. https:\/\/doi.org\/10.1007\/s00198-017-4151-8.","journal-title":"Osteoporos Int"},{"issue":"2","key":"941_CR58","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/ncprheum0423","volume":"3","author":"SM Bierma-Zeinstra","year":"2007","unstructured":"Bierma-Zeinstra SM, Koes BW. Risk factors and prognostic factors of hip and knee osteoarthritis. Nat Clin Pract Rheumatol. 2007;3(2):78\u201385. https:\/\/doi.org\/10.1038\/ncprheum0423.","journal-title":"Nat Clin Pract Rheumatol"},{"issue":"2","key":"941_CR59","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1002\/art.20136","volume":"50","author":"J Rogers","year":"2004","unstructured":"Rogers J, Shepstone L, Dieppe P. Is osteoarthritis a systemic disorder of bone? Arthritis Rheum. 2004;50(2):452\u20137. https:\/\/doi.org\/10.1002\/art.20136.","journal-title":"Arthritis Rheum"},{"issue":"8065","key":"941_CR60","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1038\/s41586-025-08771-z","volume":"641","author":"K Hatzikotoulas","year":"2025","unstructured":"Hatzikotoulas K, Southam L, Stefansdottir L, Boer CG, McDonald ML, Pett JP, et al. Translational genomics of osteoarthritis in 1,962,069 individuals. Nature. 2025;641(8065):1217\u201324. https:\/\/doi.org\/10.1038\/s41586-025-08771-z.","journal-title":"Nature"},{"issue":"2","key":"941_CR61","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.cell.2022.11.001","volume":"186","author":"C Lopez-Otin","year":"2023","unstructured":"Lopez-Otin C, Blasco MA, Partridge L, Serrano M, Kroemer G. Hallmarks of aging: an expanding universe. Cell. 2023;186(2):243\u201378. https:\/\/doi.org\/10.1016\/j.cell.2022.11.001.","journal-title":"Cell"},{"issue":"3","key":"941_CR62","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1093\/rheumatology\/keac415","volume":"62","author":"IA Szilagyi","year":"2023","unstructured":"Szilagyi IA, Vallerga CL, Boer CG, Schiphof D, Ikram MA, Bierma-Zeinstra SMA, et al. Plasma proteomics identifies CRTAC1 as a biomarker for osteoarthritis severity and progression. Rheumatology (Oxford). 2023;62(3):1286\u201395. https:\/\/doi.org\/10.1093\/rheumatology\/keac415.","journal-title":"Rheumatology (Oxford)"},{"issue":"12","key":"941_CR63","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1016\/j.joca.2011.09.005","volume":"19","author":"JM Hoch","year":"2011","unstructured":"Hoch JM, Mattacola CG, Medina McKeon JM, Howard JS, Lattermann C. Serum cartilage oligomeric matrix protein (sCOMP) is elevated in patients with knee osteoarthritis: a systematic review and meta-analysis. Osteoarthritis Cartilage. 2011;19(12):1396\u2013404. https:\/\/doi.org\/10.1016\/j.joca.2011.09.005.","journal-title":"Osteoarthritis Cartilage"},{"issue":"2","key":"941_CR64","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.joca.2022.09.005","volume":"31","author":"FAC Rocha","year":"2023","unstructured":"Rocha FAC, Ali SA. Soluble biomarkers in osteoarthritis in 2022: year in review. Osteoarthritis Cartilage. 2023;31(2):167\u201376. https:\/\/doi.org\/10.1016\/j.joca.2022.09.005.","journal-title":"Osteoarthritis Cartilage"},{"issue":"12","key":"941_CR65","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1136\/ard-2023-224459","volume":"82","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Xie J, Wen S, Cao P, Xiao W, Zhu J, et al. Evaluating the causal effect of circulating proteome on the risk of osteoarthritis-related traits. Ann Rheum Dis. 2023;82(12):1606\u201317. https:\/\/doi.org\/10.1136\/ard-2023-224459.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"941_CR66","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/s00296-025-05792-9","volume":"45","author":"R Moraliyska","year":"2025","unstructured":"Moraliyska R, Georgiev T. Biochemical markers in hand osteoarthritis: a path to precision medicine. Rheumatol Int. 2025;45(2):38. https:\/\/doi.org\/10.1007\/s00296-025-05792-9.","journal-title":"Rheumatol Int"},{"issue":"3","key":"941_CR67","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1111\/cge.13680","volume":"97","author":"B Zhang","year":"2020","unstructured":"Zhang B, Zhang Y, Wu N, Li J, Liu H, Wang J. Integrated analysis of COL2A1 variant data and classification of type II collagenopathies. Clin Genet. 2020;97(3):383\u201395. https:\/\/doi.org\/10.1111\/cge.13680.","journal-title":"Clin Genet"},{"key":"941_CR68","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aag1166","author":"C Finan","year":"2017","unstructured":"Finan C, Gaulton A, Kruger FA, Lumbers RT, Shah T, Engmann J, et al. The druggable genome and support for target identification and validation in drug development. Sci Transl Med. 2017. https:\/\/doi.org\/10.1126\/scitranslmed.aag1166.","journal-title":"Sci Transl Med"},{"issue":"1","key":"941_CR69","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/s41467-021-20918-w","volume":"12","author":"G Jones","year":"2021","unstructured":"Jones G, Trajanoska K, Santanasto AJ, Stringa N, Kuo CL, Atkins JL, et al. Genome-wide meta-analysis of muscle weakness identifies 15 susceptibility loci in older men and women. Nat Commun. 2021;12(1):654. https:\/\/doi.org\/10.1038\/s41467-021-20918-w.","journal-title":"Nat Commun"},{"issue":"1","key":"941_CR70","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-07567-9","volume":"12","author":"H Jin","year":"2022","unstructured":"Jin H, Yoo HJ, Kim YA, Lee JH, Lee Y, Kwon SH, et al. Unveiling genetic variants for age-related sarcopenia by conducting a genome-wide association study on Korean cohorts. Sci Rep. 2022;12(1):3501. https:\/\/doi.org\/10.1038\/s41598-022-07567-9.","journal-title":"Sci Rep"},{"issue":"1","key":"941_CR71","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s00223-024-01312-2","volume":"116","author":"S Ran","year":"2025","unstructured":"Ran S, Lin X, Wang S, Li Z, Liu B. Multi-trait genome-wide analysis identified 20 novel loci for sarcopenia-related traits in UK biobank. Calcif Tissue Int. 2025;116(1):10. https:\/\/doi.org\/10.1007\/s00223-024-01312-2.","journal-title":"Calcif Tissue Int"},{"issue":"1","key":"941_CR72","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s40520-024-02903-7","volume":"37","author":"Q Lin","year":"2024","unstructured":"Lin Q, Li K, Li L, Guan L, Zeng Y, Cai D, et al. Plasma biomarkers in patients with age-related sarcopenia: a proteomic exploration and experimental validation. Aging Clin Exp Res. 2024;37(1):13. https:\/\/doi.org\/10.1007\/s40520-024-02903-7.","journal-title":"Aging Clin Exp Res"},{"issue":"3","key":"941_CR73","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1002\/jcsm.12692","volume":"12","author":"J Dong","year":"2021","unstructured":"Dong J, Yu J, Li Z, Gao S, Wang H, Yang S, et al. Serum insulin-like growth factor binding protein 2 levels as biomarker for pancreatic ductal adenocarcinoma-associated malnutrition and muscle wasting. J Cachexia Sarcopenia Muscle. 2021;12(3):704\u201316. https:\/\/doi.org\/10.1002\/jcsm.12692.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"Pt B","key":"941_CR74","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.cbi.2016.05.036","volume":"259","author":"CE Furlong","year":"2016","unstructured":"Furlong CE, Marsillach J, Jarvik GP, Costa LG. Paraoxonases-1, -2 and -3: what are their functions? Chem Biol Interact. 2016;259(Pt B):51\u201362. https:\/\/doi.org\/10.1016\/j.cbi.2016.05.036.","journal-title":"Chem Biol Interact"},{"issue":"2\u20134","key":"941_CR75","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.imbio.2005.05.010","volume":"210","author":"BO Fabriek","year":"2005","unstructured":"Fabriek BO, Dijkstra CD, van den Berg TK. The macrophage scavenger receptor CD163. Immunobiology. 2005;210(2\u20134):153\u201360. https:\/\/doi.org\/10.1016\/j.imbio.2005.05.010.","journal-title":"Immunobiology"},{"key":"941_CR76","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.81559","author":"CHJ Choi","year":"2022","unstructured":"Choi CHJ, Barr W, Zaman S, Model C, Park A, Koenen M, et al. Lrg1 is an adipokine that promotes insulin sensitivity and suppresses inflammation. Elife. 2022. https:\/\/doi.org\/10.7554\/eLife.81559.","journal-title":"Elife"},{"issue":"5","key":"941_CR77","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1002\/jcsm.13539","volume":"15","author":"P Aparicio","year":"2024","unstructured":"Aparicio P, Navarrete-Villanueva D, Gomez-Cabello A, Lopez-Royo T, Santamaria E, Fernandez-Irigoyen J, et al. Proteomic profiling of human plasma extracellular vesicles identifies PF4 and C1R as novel biomarker in sarcopenia. J Cachexia Sarcopenia Muscle. 2024;15(5):1883\u201397. https:\/\/doi.org\/10.1002\/jcsm.13539.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"941_CR78","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2023.101155","volume":"64","author":"Z Liu","year":"2024","unstructured":"Liu Z, Li L, Zhang H, Pang X, Qiu Z, Xiang Q, et al. Platelet factor 4(PF4) and its multiple roles in diseases. Blood Rev. 2024;64:101155. https:\/\/doi.org\/10.1016\/j.blre.2023.101155.","journal-title":"Blood Rev"},{"issue":"4","key":"941_CR79","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1073\/pnas.1718709115","volume":"115","author":"JOM Almitairi","year":"2018","unstructured":"Almitairi JOM, Venkatraman Girija U, Furze CM, Simpson-Gray X, Badakshi F, Marshall JE, et al. Structure of the C1r\u2013C1s interaction of the C1 complex of complement activation. Proc Natl Acad Sci U S A. 2018;115(4):768\u201373. https:\/\/doi.org\/10.1073\/pnas.1718709115.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"941_CR80","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12881-020-0977-6","volume":"21","author":"AN Singh","year":"2020","unstructured":"Singh AN, Gasman B. Disentangling the genetics of sarcopenia: prioritization of NUDT3 and KLF5 as genes for lean mass & HLA-DQB1-AS1 for hand grip strength with the associated enhancing SNPs & a scoring system. BMC Med Genet. 2020;21(1):40. https:\/\/doi.org\/10.1186\/s12881-020-0977-6.","journal-title":"BMC Med Genet"},{"issue":"4","key":"941_CR81","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1002\/jcsm.13479","volume":"15","author":"KF Yin","year":"2024","unstructured":"Yin KF, Chen T, Gu XJ, Su WM, Jiang Z, Lu SJ, et al. Systematic druggable genome-wide Mendelian randomization identifies therapeutic targets for sarcopenia. J Cachexia Sarcopenia Muscle. 2024;15(4):1324\u201334. https:\/\/doi.org\/10.1002\/jcsm.13479.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"6","key":"941_CR82","doi-asserted-by":"publisher","first-page":"526 e9","DOI":"10.1016\/j.amjmed.2005.10.049","volume":"119","author":"LA Schaap","year":"2006","unstructured":"Schaap LA, Pluijm SM, Deeg DJ, Visser M. Inflammatory markers and loss of muscle mass (sarcopenia) and strength. Am J Med. 2006;119(6):526 e9-17. https:\/\/doi.org\/10.1016\/j.amjmed.2005.10.049.","journal-title":"Am J Med."},{"key":"941_CR83","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2021.111544","volume":"154","author":"L Pan","year":"2021","unstructured":"Pan L, Xie W, Fu X, Lu W, Jin H, Lai J, et al. Inflammation and sarcopenia: a focus on circulating inflammatory cytokines. Exp Gerontol. 2021;154:111544. https:\/\/doi.org\/10.1016\/j.exger.2021.111544.","journal-title":"Exp Gerontol"},{"issue":"4","key":"941_CR84","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1002\/jcsm.13513","volume":"15","author":"RS Kamper","year":"2024","unstructured":"Kamper RS, Nygaard H, Praeger-Jahnsen L, Ekmann A, Ditlev SB, Schultz M, et al. GDF-15 is associated with sarcopenia and frailty in acutely admitted older medical patients. J Cachexia Sarcopenia Muscle. 2024;15(4):1549\u201357. https:\/\/doi.org\/10.1002\/jcsm.13513.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"3","key":"941_CR85","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1002\/jcp.20778","volume":"209","author":"V Siriett","year":"2006","unstructured":"Siriett V, Platt L, Salerno MS, Ling N, Kambadur R, Sharma M. Prolonged absence of myostatin reduces sarcopenia. J Cell Physiol. 2006;209(3):866\u201373. https:\/\/doi.org\/10.1002\/jcp.20778.","journal-title":"J Cell Physiol"},{"issue":"5","key":"941_CR86","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1002\/jcsm.12204","volume":"8","author":"Z Xu","year":"2017","unstructured":"Xu Z, Feng X, Dong J, Wang ZM, Lee J, Furdui C, et al. Cardiac troponin T and fast skeletal muscle denervation in ageing. J Cachexia Sarcopenia Muscle. 2017;8(5):808\u201323. https:\/\/doi.org\/10.1002\/jcsm.12204.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"3","key":"941_CR87","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1007\/s00223-022-01049-w","volume":"112","author":"BX Han","year":"2023","unstructured":"Han BX, Yan SS, Yu H, Xu Q, Zhao QG, Ma XL, et al. Causal effects of plasma proteome on osteoporosis and osteoarthritis. Calcif Tissue Int. 2023;112(3):350\u20138. https:\/\/doi.org\/10.1007\/s00223-022-01049-w.","journal-title":"Calcif Tissue Int"},{"issue":"3","key":"941_CR88","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/ncprheum0727","volume":"4","author":"G Murphy","year":"2008","unstructured":"Murphy G, Nagase H. Reappraising metalloproteinases in rheumatoid arthritis and osteoarthritis: destruction or repair? Nat Clin Pract Rheumatol. 2008;4(3):128\u201335. https:\/\/doi.org\/10.1038\/ncprheum0727.","journal-title":"Nat Clin Pract Rheumatol"},{"issue":"2","key":"941_CR89","doi-asserted-by":"publisher","DOI":"10.1111\/acel.14035","volume":"23","author":"J Xu","year":"2024","unstructured":"Xu J, Cai X, Miao Z, Yan Y, Chen D, Yang ZX, et al. Proteome-wide profiling reveals dysregulated molecular features and accelerated aging in osteoporosis: a 9.8-year prospective study. Aging Cell. 2024;23(2):e14035. https:\/\/doi.org\/10.1111\/acel.14035.","journal-title":"Aging Cell"},{"issue":"6","key":"941_CR90","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1111\/acel.12661","volume":"16","author":"EK Laakkonen","year":"2017","unstructured":"Laakkonen EK, Soliymani R, Karvinen S, Kaprio J, Kujala UM, Baumann M, et al. Estrogenic regulation of skeletal muscle proteome: a study of premenopausal women and postmenopausal MZ cotwins discordant for hormonal therapy. Aging Cell. 2017;16(6):1276\u201387. https:\/\/doi.org\/10.1111\/acel.12661.","journal-title":"Aging Cell"},{"issue":"1","key":"941_CR91","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/nrg3356","volume":"14","author":"AF Altelaar","year":"2013","unstructured":"Altelaar AF, Munoz J, Heck AJ. Next-generation proteomics: towards an integrative view of proteome dynamics. Nat Rev Genet. 2013;14(1):35\u201348. https:\/\/doi.org\/10.1038\/nrg3356.","journal-title":"Nat Rev Genet"},{"issue":"7975","key":"941_CR92","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1038\/s41586-023-06388-8","volume":"620","author":"K Trajanoska","year":"2023","unstructured":"Trajanoska K, Bherer C, Taliun D, Zhou S, Richards JB, Mooser V. From target discovery to clinical drug development with human genetics. Nature. 2023;620(7975):737\u201345. https:\/\/doi.org\/10.1038\/s41586-023-06388-8.","journal-title":"Nature"},{"issue":"17","key":"941_CR93","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1161\/CIRCULATIONAHA.116.025446","volume":"135","author":"JG Smith","year":"2017","unstructured":"Smith JG, Gerszten RE. Emerging affinity-based proteomic technologies for large-scale plasma profiling in cardiovascular disease. Circulation. 2017;135(17):1651\u201364. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.116.025446.","journal-title":"Circulation"},{"issue":"3","key":"941_CR94","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/nmeth.2369","volume":"10","author":"LM Smith","year":"2013","unstructured":"Smith LM, Kelleher NL, Consortium for Top Down P. Proteoform: a single term describing protein complexity. Nat Methods. 2013;10(3):186\u20137. https:\/\/doi.org\/10.1038\/nmeth.2369.","journal-title":"Nat Methods"},{"issue":"1","key":"941_CR95","doi-asserted-by":"publisher","first-page":"6822","DOI":"10.1038\/s41467-021-27164-0","volume":"12","author":"M Pietzner","year":"2021","unstructured":"Pietzner M, Wheeler E, Carrasco-Zanini J, Kerrison ND, Oerton E, Koprulu M, et al. Synergistic insights into human health from aptamer- and antibody-based proteomic profiling. Nat Commun. 2021;12(1):6822. https:\/\/doi.org\/10.1038\/s41467-021-27164-0.","journal-title":"Nat Commun"},{"issue":"7982","key":"941_CR96","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/s41586-023-06563-x","volume":"622","author":"GH Eldjarn","year":"2023","unstructured":"Eldjarn GH, Ferkingstad E, Lund SH, Helgason H, Magnusson OT, Gunnarsdottir K, et al. Large-scale plasma proteomics comparisons through genetics and disease associations. Nature. 2023;622(7982):348\u201358. https:\/\/doi.org\/10.1038\/s41586-023-06563-x.","journal-title":"Nature"},{"issue":"1","key":"941_CR97","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1038\/s41467-025-56935-2","volume":"16","author":"B Wang","year":"2025","unstructured":"Wang B, Pozarickij A, Mazidi M, Wright N, Yao P, Said S, et al. Comparative studies of 2168 plasma proteins measured by two affinity-based platforms in 4000 Chinese adults. Nat Commun. 2025;16(1):1869. https:\/\/doi.org\/10.1038\/s41467-025-56935-2.","journal-title":"Nat Commun"},{"key":"941_CR98","doi-asserted-by":"publisher","unstructured":"Consortium GT, Laboratory DA, Coordinating Center -Analysis Working G, Statistical Methods groups-Analysis Working G, Enhancing Gg, Fund NIHC, et al. Genetic effects on gene expression across human tissues. Nature. 2017;550(7675):204\u201313. https:\/\/doi.org\/10.1038\/nature24277","DOI":"10.1038\/nature24277"},{"key":"941_CR99","doi-asserted-by":"publisher","unstructured":"Su CY, van der Graaf A, Zhang W, Jang D-K, Selber-Hnatiw S, Yang TY, et al. Multi-ancestry proteome-phenome-wide Mendelian randomization offers a comprehensive protein-disease atlas and potential therapeutic targets. medRxiv. 2024;2024.10.17.24315553. https:\/\/doi.org\/10.1101\/2024.10.17.24315553","DOI":"10.1101\/2024.10.17.24315553"}],"container-title":["Current Osteoporosis Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11914-025-00941-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11914-025-00941-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11914-025-00941-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T10:56:11Z","timestamp":1768474571000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11914-025-00941-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,11]]},"references-count":99,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["941"],"URL":"https:\/\/doi.org\/10.1007\/s11914-025-00941-2","relation":{},"ISSN":["1544-1873","1544-2241"],"issn-type":[{"value":"1544-1873","type":"print"},{"value":"1544-2241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,11]]},"assertion":[{"value":"21 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"D.P.K. has received institutional grants from Amgen, Radius Health and Solarea Bio, serves on a data safety and monitoring committee for Agnovos, serves on scientific advisory boards for Solarea Bio and Radius Health, and receives royalties for publication from Wolters Kluwer for UpToDate. S.Y. serves as an Analytical Consultant for the Broad Institute of MIT and Harvard under contract with Precision Global Consulting. M.H. and C.-Y.S. report no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"43"}}